
Four players have dropped their lawsuit against the PGA Tour but, in their absence, the rival Saudi-backed LIV Golf circuit has now joined in.
An amended complaint filed in the U.S. District Court in Northern California on Friday reflected the addition of LIV Golf to the antitrust lawsuit and the withdrawal of four names – Pat Perez and Carlos Oritiz, who previously announced their decision to drop the lawsuit, and Abraham Ancer and Jason Kokrak.
Phil Mickelson and 10 other golfers filed an antitrust lawsuit against the PGA Tour earlier this month, claiming that its indefinite suspensions were aimed at hurting their careers. Three other golfers also filed for a temporary restraining order to compete in the FedEx Cup playoffs, arguing that they qualified before joining LIV Golf – an injunction that was later denied by a federal judge in California.
Three-time PGA Tour winner Pat Perez told Sports Illustrated that he initially joined the lawsuit to “back our guys,” but added that he didn’t want “to go after the PGA Tour.”
“I have no ill feelings toward the PGA Tour or any of the players. I’m a LIV guy 100%,” Perez told the outlet. “I’m going to play for them. But I don’t feel any need to go after the PGA Tour. They gave me a wonderful opportunity for 21 years. I’ve got nothing against them, no hard feelings toward anybody. I earned everything I got out there, don’t get me wrong.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
BCLP Strengthens Healthcare and Antitrust Litigation Practice
May 19, 2025 by
CPI
Italy Fines AI Chatbot Maker Replika €5 Million Over Privacy Violations
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas